Search research articles
Contact Us
Filters
Showing results (121-130 of 163) with videos related to
Page
of 17
Sort By:
Molecular and Cellular Biochemistry
|
October 27, 1998
Biological effects of a relatively low concentration of 1-beta-D-arabinofuranosylcytosine in K562 cells: alterations of the cell cycle, erythroid-differentiation, and apoptosis
H Yamada, J Horiguchi-Yamada, M Nagai, et al.
Cancer Letters
|
July 29, 1999
Interferon-alpha repressed telomerase along with G1-accumulation of Daudi cells
M Akiyama, S Iwase, J Horiguchi-Yamada, et al.
International Journal of Hematology
|
December 1, 1996
Herbimycin A down-regulates messages of cyclin D1 and c-myc during erythroid differentiation of K562 cells
H Yamada, S Iwase, M Nagai, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
September 1, 1991
[Altered expression of protooncogenes during clinical course in an AML case transformed from MDS]
T Fujikawa, J Horiguchi, K Iizuka, et al.
International Journal of Molecular Medicine
|
July 14, 1999
The mechanisms of antitumor effects of luteinizing hormone-releasing hormone agonist (buserelin) in 7, 12-dimethylbenz(a)anthracene-induced rat mammary cancer
Y Koibuchi, N Sugamata, Y Iino, et al.
Oncology Reports
|
April 16, 1999
Effects of interferon-alpha on cellular proliferation and adhesion of breast carcinoma cells
M Maemura, Y Iino, J Horiguchi, et al.
Oncology Reports
|
December 29, 1998
Surgical margin and breast recurrence after breast-conserving therapy
J Horiguchi, Y Iino, H Takei, et al.
Anticancer Research
|
November 1, 1994
Clinical significance of first line treatment in recurrent breast cancer
Y Iino, H Aoyagi, T Takeo, et al.
Oncology Reports
|
May 19, 2011
Combination chemoendocrine therapy containing vindesine for refractory metastatic breast cancer
M Maemura, Y Iino, T Yokoe, et al.
Anticancer Research
|
September 1, 1996
Multidisciplinary treatment with anthracyclines in inflammatory breast cancer
Y Iino, H Takei, M Maemura, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 163) with videos related to
Sort By:
Page
of 17
Molecular and Cellular Biochemistry
|
October 27, 1998
Biological effects of a relatively low concentration of 1-beta-D-arabinofuranosylcytosine in K562 cells: alterations of the cell cycle, erythroid-differentiation, and apoptosis
H Yamada, J Horiguchi-Yamada, M Nagai, et al.
Cancer Letters
|
July 29, 1999
Interferon-alpha repressed telomerase along with G1-accumulation of Daudi cells
M Akiyama, S Iwase, J Horiguchi-Yamada, et al.
International Journal of Hematology
|
December 1, 1996
Herbimycin A down-regulates messages of cyclin D1 and c-myc during erythroid differentiation of K562 cells
H Yamada, S Iwase, M Nagai, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
September 1, 1991
[Altered expression of protooncogenes during clinical course in an AML case transformed from MDS]
T Fujikawa, J Horiguchi, K Iizuka, et al.
International Journal of Molecular Medicine
|
July 14, 1999
The mechanisms of antitumor effects of luteinizing hormone-releasing hormone agonist (buserelin) in 7, 12-dimethylbenz(a)anthracene-induced rat mammary cancer
Y Koibuchi, N Sugamata, Y Iino, et al.
Oncology Reports
|
April 16, 1999
Effects of interferon-alpha on cellular proliferation and adhesion of breast carcinoma cells
M Maemura, Y Iino, J Horiguchi, et al.
Oncology Reports
|
December 29, 1998
Surgical margin and breast recurrence after breast-conserving therapy
J Horiguchi, Y Iino, H Takei, et al.
Anticancer Research
|
November 1, 1994
Clinical significance of first line treatment in recurrent breast cancer
Y Iino, H Aoyagi, T Takeo, et al.
Oncology Reports
|
May 19, 2011
Combination chemoendocrine therapy containing vindesine for refractory metastatic breast cancer
M Maemura, Y Iino, T Yokoe, et al.
Anticancer Research
|
September 1, 1996
Multidisciplinary treatment with anthracyclines in inflammatory breast cancer
Y Iino, H Takei, M Maemura, et al.
Page
of 17